Comparison of three approaches for inhibiting insulin-like growth factor I receptor and their effects on NSCLC cell linesin vitro-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Comparison of three approaches for inhibiting insulin-like growth factor I receptor and their effects on NSCLC cell linesin vitro

Published:2007-01 Issue:1 Volume:25 Page:1-8
ISSN:0897-7194
Container-title:Growth Factors
language:en
Short-container-title:Growth Factors

Author:

Cosaceanu Daria,Carapancea Mia,Alexandru Oana,Budiu Raluca,Martinsson Hanna-Stina,Starborg Maria,Vrabete Maria,Kanter Lena,Lewensohn Rolf,Dricu Anica

Publisher

Informa UK Limited

Subject

Cell Biology,Clinical Biochemistry,Endocrinology

Link

http://www.tandfonline.com/doi/pdf/10.1080/08977190600702865

Reference32 articles.

1. The insulin like growth factor-1 receptor (IGF-1R) as a drug target: novel approaches to cancer therapy

2. The contradictions of the insulin-like growth factor 1 receptor

3. The IGF-1 receptor in cancer biology

4. Substrate Competitive Inhibitors of IGF-1 Receptor Kinase

5. Inhibition of the type I insulin-like growth factor receptor expression and signaling: Novel strategies for antimetastatic therapy

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeted immunotherapy for glioblastoma involving whole tumor-derived autologous cells in the upfront setting after craniotomy;Journal of Neuro-Oncology;2023-11-29

2. The effects of lead exposure on the expression of IGF1R, IGFBP3, Aβ40, and Aβ42 in PC12 cells;Journal of Trace Elements in Medicine and Biology;2022-01

3. Glioblastoma pharmacotherapy: A multifaceted perspective of conventional and emerging treatments (Review);Experimental and Therapeutic Medicine;2021-10-06

4. Phase Ib Clinical Trial of IGV-001 for Patients with Newly Diagnosed Glioblastoma;Clinical Cancer Research;2021-01-26

5. Receptor tyrosine kinase targeting in glioblastoma: performance, limitations and future approaches;Współczesna Onkologia;2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3